169 related articles for article (PubMed ID: 31706582)
1. Acute Elevations in Cortisol Increase the In Vivo Binding of [
Flanigan M; Tollefson S; Himes ML; Jordan R; Roach K; Stoughton C; Lopresti B; Mason NS; Ciccocioppo R; Narendran R
Biol Psychiatry; 2020 Mar; 87(6):570-576. PubMed ID: 31706582
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [
Narendran R; Tollefson S; Himes ML; Paris J; Lopresti B; Ciccocioppo R; Mason NS
Am J Psychiatry; 2019 Jun; 176(6):468-476. PubMed ID: 31055968
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [
Narendran R; Ciccocioppo R; Lopresti B; Paris J; Himes ML; Mason NS
Biol Psychiatry; 2018 Nov; 84(10):708-714. PubMed ID: 28711193
[TBL] [Abstract][Full Text] [Related]
4. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
[TBL] [Abstract][Full Text] [Related]
5. Decreased Nociceptin Receptors Are Related to Resilience and Recovery in College Women Who Have Experienced Sexual Violence: Therapeutic Implications for Posttraumatic Stress Disorder.
Narendran R; Tollefson S; Fasenmyer K; Paris J; Himes ML; Lopresti B; Ciccocioppo R; Mason NS
Biol Psychiatry; 2019 Jun; 85(12):1056-1064. PubMed ID: 30954231
[TBL] [Abstract][Full Text] [Related]
6. Imaging Nociceptin Opioid Peptide Receptors in Alcohol Use Disorder With [
Tollefson S; Stoughton C; Himes ML; McKinney KE; Mason S; Ciccocioppo R; Narendran R
Biol Psychiatry; 2023 Sep; 94(5):416-423. PubMed ID: 36906499
[TBL] [Abstract][Full Text] [Related]
7. Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
Kimura Y; Fujita M; Hong J; Lohith TG; Gladding RL; Zoghbi SS; Tauscher JA; Goebl N; Rash KS; Chen Z; Pedregal C; Barth VN; Pike VW; Innis RB
J Nucl Med; 2011 Oct; 52(10):1638-45. PubMed ID: 21880575
[TBL] [Abstract][Full Text] [Related]
8. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
Lohith TG; Zoghbi SS; Morse CL; Araneta MF; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
J Nucl Med; 2012 Mar; 53(3):385-92. PubMed ID: 22312136
[TBL] [Abstract][Full Text] [Related]
9. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
Nazzaro C; Barbieri M; Varani K; Beani L; Valentino RJ; Siniscalchi A
Neuropharmacology; 2010 Feb; 58(2):457-64. PubMed ID: 19747494
[TBL] [Abstract][Full Text] [Related]
10. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
12. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
13. Imaging corticotropin-releasing-factor and nociceptin in addiction and PTSD models.
Tollefson S; Himes M; Narendran R
Int Rev Psychiatry; 2017 Dec; 29(6):567-579. PubMed ID: 29231765
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
15. NOP receptors in the prelimbic cortex have an inhibitory influence on cardiovascular responses induced by restraint stress.
Fassini A; Scopinho AA; Resstel LB; Corrêa FM
Neuropeptides; 2016 Jun; 57():35-44. PubMed ID: 26935148
[TBL] [Abstract][Full Text] [Related]
16. Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects.
Raddad E; Chappell A; Meyer J; Wilson A; Ruegg CE; Tauscher J; Statnick MA; Barth V; Zhang X; Verfaille SJ
Drug Metab Dispos; 2016 Sep; 44(9):1536-42. PubMed ID: 27353045
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress.
Gavioli EC; Holanda VAD; Calo G; Ruzza C
Peptides; 2021 Jul; 141():170548. PubMed ID: 33862163
[TBL] [Abstract][Full Text] [Related]
18. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri NT
Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats.
Caputi FF; Stopponi S; Rullo L; Palmisano M; Ubaldi M; Candeletti S; Ciccocioppo R; Romualdi P
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671048
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
Green MK; Devine DP
Neuropeptides; 2009 Dec; 43(6):507-14. PubMed ID: 19720395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
